Market Report, "Signal Genetics LLC - Product Pipeline Analysis, 2013 Update", Published
Signal Genetics LLC (Signal Genetics) is a commercial stage, molecular diagnostic company. The company provides diagnostic services that help the physicians to make better informed decisions relating to the care of their patients suffering from cancer. It follows MyPRS Plus testing methodology, which is a microarray-based gene expression profiling assay used to assist the management of patients with multiple myeloma and related disorders. Signal Genetics' research laboratory performs cell-sorting, isolation and gene expression profiling services for pharmaceutical and research organizations...
View full press release